Contribution of Interleukin-6 system genes polymorphisms to the development of coronary atherosclerosis

Yulia A Shuvalova1, Victoria Kaminnaya2, Alexander I Kaminnyi1

  • 1FSBI Academician E I Chazov National Medical Research Centre of Cardiology of the Ministry of Health of the Russian Federation, Department of Atherosclerosis Problems, 3rd Cherepkovskaya str, 15a, Moscow 121552, Russia.

Gene
|February 8, 2023
PubMed

Insights

Coronary artery disease (CAD) is a major cause of death. This review explores the genetic factors, focusing on the interleukin-6 system, contributing to atherosclerosis development and prevention strategies.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Immunology

Background:

  • Coronary artery disease (CAD) is a leading cause of cardiovascular morbidity and mortality.
  • Atherosclerosis risk involves complex genetic, environmental, and lifestyle interactions.
  • Aging populations are projected to increase CAD prevalence, highlighting prevention needs.

Purpose of the Study:

  • To review current knowledge on the genetics of atherosclerosis.
  • To specifically examine the role of the interleukin-6 (IL-6) system in coronary atherosclerosis development.

Main Methods:

  • Literature review and synthesis of existing research.
  • Focus on genetic studies related to atherosclerosis.
  • Analysis of the interleukin-6 system's genetic components and pathways.

Main Results:

  • Significant advancements in understanding atherosclerosis genetics have occurred.
  • The interleukin-6 system is implicated in the pathogenesis of coronary atherosclerosis.
  • Genetic variations within the IL-6 system may influence disease susceptibility.

Conclusions:

  • Understanding the genetic basis of CAD, particularly the IL-6 system, is crucial for effective prevention.
  • Further research into IL-6 genetics can inform targeted therapeutic strategies.
  • Genetics plays a significant role in atherosclerosis, necessitating personalized prevention approaches.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
42
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
20
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
30
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.8K